<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: EMPA REG OUTCOME® Renal	</title>
	<atom:link href="https://www.bcdiabetes.ca/empa-reg-outcome-renal/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.bcdiabetes.ca/empa-reg-outcome-renal/</link>
	<description>British Columbia Diabetes Care, Research, and Education</description>
	<lastBuildDate>Tue, 05 Feb 2019 23:34:18 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
	<item>
		<title>
		By: bcdiabetes.ca &#124; BC is a third-world country when it comes to covering life-saving medication for diabetes		</title>
		<link>https://www.bcdiabetes.ca/empa-reg-outcome-renal/#comment-6</link>

		<dc:creator><![CDATA[bcdiabetes.ca &#124; BC is a third-world country when it comes to covering life-saving medication for diabetes]]></dc:creator>
		<pubDate>Fri, 28 Oct 2016 01:16:14 +0000</pubDate>
		<guid isPermaLink="false">https://www.bcdiabetes.ca/?p=1122#comment-6</guid>

					<description><![CDATA[[&#8230;] A life saving class of diabetes oral medication, SGLT2 inhibitors, costing less than $3/day, is not covered in British Columbia, but is covered in the rest of Canada.  I asked Dr. Elliott, Medical Director of BCDiabetes.ca for his comments.  Dr. Elliott has already blogged twice on this class of medication (see https://www.bcdiabetes.ca/third-sglt2-inhibitor-in-canada/ &#038; https://www.bcdiabetes.ca/empa-reg-outcome-renal/ [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] A life saving class of diabetes oral medication, SGLT2 inhibitors, costing less than $3/day, is not covered in British Columbia, but is covered in the rest of Canada.  I asked Dr. Elliott, Medical Director of BCDiabetes.ca for his comments.  Dr. Elliott has already blogged twice on this class of medication (see <a href="https://www.bcdiabetes.ca/third-sglt2-inhibitor-in-canada/" rel="ugc" data-wpel-link="internal">https://www.bcdiabetes.ca/third-sglt2-inhibitor-in-canada/</a> &amp; <a href="https://www.bcdiabetes.ca/empa-reg-outcome-renal/" rel="ugc" data-wpel-link="internal">https://www.bcdiabetes.ca/empa-reg-outcome-renal/</a> [&#8230;]</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
